Clinical trial
REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With…
NCT00378352 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00378352 |
|---|---|
| Title | REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction |
| Official title | Effects of Erythropoietin on Infarct Size and Left Ventricular Remodeling in Survivors of Large Myocardial Infarctions |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute ST Elevation Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 223 |
| Start date | Sep 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jan 1, 2011 |
| First posted | Sep 20, 2006 |
| Last update posted | May 9, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: